ClinConnect ClinConnect Logo
Search / Trial NCT06989970

Treating Traumatic Brain Injury With Transcranial Direct Current Stimulation

Launched by JOHNS HOPKINS UNIVERSITY · May 19, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

Tbi Traumatic Brain Injury Chronic Traumatic Brain Injury Transcranial Direct Current Stimulation T Dcs Computerized Cognitive Therapy

ClinConnect Summary

This clinical trial is exploring a new treatment for people who have experienced a traumatic brain injury (TBI) at least two years ago. The focus is on using a method called transcranial direct current stimulation (tDCS), which is a safe and non-invasive technique that delivers a gentle electrical current to stimulate the brain. The goal is to see if combining tDCS with cognitive training can help improve thinking skills and decision-making in individuals with TBI. This approach is personalized, meaning that the treatment will be tailored to meet the specific needs of each participant.

To be eligible for this trial, participants must be right-handed, able to speak English, and have been diagnosed with TBI at least two years prior. However, individuals with certain conditions, such as uncorrected vision or hearing problems, or those who have had a stroke or other serious brain issues, cannot participate. The trial is currently not recruiting participants, but once it begins, those who qualify can expect to receive targeted brain stimulation alongside cognitive exercises designed to help improve their everyday functioning.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of traumatic brain injury (TBI) at least 2 years prior to participation
  • Right-handed
  • English - speaking
  • Exclusion Criteria:
  • Uncorrected visual impairment
  • Uncorrected hearing impairment
  • Stroke or other premorbid neurological disorders affecting the brain
  • Premorbid learning disorders
  • MRI Exclusion Criteria:
  • severe claustrophobia
  • Cardiac pacemakers, ferromagnetic implants, cochlear implants
  • pregnant woman

About Johns Hopkins University

Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.

Locations

Patients applied

0 patients applied

Trial Officials

Kyrana Tsapkini, PhD.

Principal Investigator

Johns Hopkins University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported